Partner Content Partner Content BioPharmaLogic, Antikor Biopharma and UCL Host 2 Must Attend... ADC Summit
Partner Content Partner Content Exclusive Interview Released with HPAPI Project Services SMi's 2nd Annual HPAPI 2018 Conference
Partner Content Partner Content BioPharmaLogic, Antikor Biopharma and UCL Host Two Workshops... SMi's 6th annual ADC Conference
Partner Content Partner Content Exclusive Speaker Interview from Seattle Genetics for SMi’s ... Interview from Seattle Genetics
Partner Content Partner Content Hear the Keynote Addresses from MedImmune and Spirogen this ... Antibodies & Antibody Drug Conjugates
Partner Content Partner Content Hear from Janssen and Antikor Biopharma at SMi’s ADC Confere... Janssen and Antikor Biopharma Speak this April
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.